These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31702806)

  • 21. Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis.
    Chen E; Qin X; Peng K; Xu X; Li W; Cheng X; Tang C; Cui Y; Wang Z; Liu T
    Cell Physiol Biochem; 2018; 45(5):1731-1746. PubMed ID: 29495008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CXCR3 expression in colorectal cancer cells enhanced invasion through preventing CXCR4 internalization.
    Jin J; Zhang Z; Wang H; Zhan Y; Li G; Yang H; Fei Z; Xu Y; Li W
    Exp Cell Res; 2018 Oct; 371(1):162-174. PubMed ID: 30092218
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
    Fan CN; Ma L; Liu N
    J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct prognostic values of ALDH1 isoenzymes in breast cancer.
    Wu S; Xue W; Huang X; Yu X; Luo M; Huang Y; Liu Y; Bi Z; Qiu X; Bai S
    Tumour Biol; 2015 Apr; 36(4):2421-6. PubMed ID: 25582316
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prognostic model comprising pT stage, N status, and the chemokine receptors CXCR4 and CXCR7 powerfully predicts outcome in neoadjuvant resistant rectal cancer patients.
    D'Alterio C; Avallone A; Tatangelo F; Delrio P; Pecori B; Cella L; Pelella A; D'Armiento FP; Carlomagno C; Bianco F; Silvestro L; Pacelli R; Napolitano M; Iaffaioli RV; Scala S
    Int J Cancer; 2014 Jul; 135(2):379-90. PubMed ID: 24375277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
    Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
    J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A chemokine/chemokine receptor signature potentially predicts clinical outcome in colorectal cancer patients.
    Mitchell A; Hasanali SL; Morera DS; Baskar R; Wang X; Khan R; Talukder A; Li CS; Manoharan M; Jordan AR; Wang J; Bollag RJ; Singh N; Albo D; Ghosh S; Lokeshwar VB
    Cancer Biomark; 2019; 26(3):291-301. PubMed ID: 31524146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Possible Diagnostic Application of CXCL12 and CXCR4 as Tumor Markers in Breast Cancer Patients.
    Dąbrowska E; Przylipiak A; Zajkowska M; Piskor BM; Sidorkiewicz I; Szmitkowski M; Lawicki S
    Anticancer Res; 2020 Jun; 40(6):3221-3229. PubMed ID: 32487616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction.
    Sun Y; Yang M; Zhang Q
    Ann Transl Med; 2022 Dec; 10(24):1379. PubMed ID: 36660642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of CXCR3 and CXCR4 in colorectal cancer metastasis.
    Murakami T; Kawada K; Iwamoto M; Akagami M; Hida K; Nakanishi Y; Kanda K; Kawada M; Seno H; Taketo MM; Sakai Y
    Int J Cancer; 2013 Jan; 132(2):276-87. PubMed ID: 22689289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive analysis of the lncRNA‑associated competing endogenous RNA network in breast cancer.
    Wang JJ; Huang YQ; Song W; Li YF; Wang H; Wang WJ; Huang M
    Oncol Rep; 2019 Dec; 42(6):2572-2582. PubMed ID: 31638237
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of chemokine CXCL12 and its receptor (CXCR4 and CXCR7) in different molecular subtypes of human breast carcinoma and the clinical significance].
    Wu W; Qian L; Dai J; Ding B; Chen X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Feb; 42(2):147-153. PubMed ID: 28255115
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD24 is a Potential Biomarker for Prognosis in Human Breast Carcinoma.
    Jing X; Cui X; Liang H; Hao C; Yang Z; Li X; Yang X; Han C
    Cell Physiol Biochem; 2018; 48(1):111-119. PubMed ID: 30001552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic values of F-box members in breast cancer: an online database analysis and literature review.
    Wang X; Zhang T; Zhang S; Shan J
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30341246
    [No Abstract]   [Full Text] [Related]  

  • 35. CXC family of chemokines as prognostic or predictive biomarkers and possible drug targets in colorectal cancer.
    Cabrero-de Las Heras S; Martínez-Balibrea E
    World J Gastroenterol; 2018 Nov; 24(42):4738-4749. PubMed ID: 30479461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization, structural and expression analysis of twelve CXC chemokines and eight CXC chemokine receptors in largemouth bass (Micropterus salmoides).
    Qi Z; Xu Y; Dong B; Pi X; Zhang Q; Wang D; Wang Z
    Dev Comp Immunol; 2023 Jun; 143():104673. PubMed ID: 36858298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CMTM5/7 are biomarkers and prognostic factors in human breast carcinoma.
    Wu J
    Cancer Biomark; 2020; 29(1):89-99. PubMed ID: 32568178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the Chemokine Receptors CXCR3, CXCR4, CXCR7 and Their Ligands in Rhabdomyosarcoma.
    San-Miguel T; Pinto S; Navarro L; Callaghan RC; Monteagudo C; López-Ginés C; Cerdá-Nicolás M; Gil-Benso R
    Pathol Oncol Res; 2015 Sep; 21(4):1191-9. PubMed ID: 26037167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer.
    Liu L; Yang J; Wang C
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32744318
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A meta-analysis for C-X-C chemokine receptor type 4 as a prognostic marker and potential drug target in hepatocellular carcinoma.
    Hu F; Miao L; Zhao Y; Xiao YY; Xu Q
    Drug Des Devel Ther; 2015; 9():3625-33. PubMed ID: 26203228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.